Related Experiment Video
Updated: Jun 25, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control
Ju-Il Kang1, Shi-Nae Kwon, Se-Hoon Park
1School of Life Sciences & Biotechnology, Korea University, 5-1 Anamdong, Seoul 136-701, Republic of Korea.
Abstract:
Hepatitis C virus (HCV) infection is currently treated with IFNalpha-based therapy but little is known how IFNalpha inhibits HCV replication. We show here that HCV JFH1 infection of human hepatoma Huh-7 cells leads to the activation of IFN-inducible protein kinase PKR and phosphorylation of the translation initiation factor eIF2alpha. Compared to a control cell HCV replication was significantly elevated in a PKR-knockdown cell, giving rise to a 10-fold higher viral titer, and was less sensitive to IFNalpha treatment. Conversely, transient expression of PKR inhibited HCV replication in a kinase-dependent manner with concomitant increase of eIF2alpha phosphorylation. Further, expression of a phospho-mimetic eIF2alpha mutant moderately inhibited HCV replication. Together, these results demonstrate that PKR is activated by HCV infection and plays a critical antiviral role through inhibition of viral protein translation.
Insights
Hepatitis C virus (HCV) infection activates protein kinase PKR, which inhibits viral replication by blocking protein translation. This finding reveals a key antiviral mechanism against HCV.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Hepatitis C virus (HCV) infection treatment relies on IFNalpha-based therapies.
- The precise mechanism by which IFNalpha inhibits HCV replication remains largely unknown.
Purpose of the Study:
- To elucidate the role of Interferon-alpha (IFNalpha)-inducible protein kinase PKR in Hepatitis C virus (HCV) replication.
- To investigate the interaction between PKR, eIF2alpha phosphorylation, and HCV replication dynamics.
Main Methods:
- HCV JFH1 infection of human hepatoma Huh-7 cells.
- PKR-knockdown cell experiments to assess viral replication.
- Transient expression of PKR and a phospho-mimetic eIF2alpha mutant.
Main Results:
- HCV infection activates PKR and phosphorylates eIF2alpha.
- PKR knockdown significantly increases HCV replication and reduces sensitivity to IFNalpha.
- PKR expression inhibits HCV replication in a kinase-dependent manner, correlating with eIF2alpha phosphorylation.
Conclusions:
- PKR is activated by HCV infection and acts as a crucial antiviral factor.
- PKR inhibits HCV replication primarily by suppressing viral protein translation via eIF2alpha phosphorylation.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Viruses with RNA Genomes
Inhibitors Of Virion Release
Inhibition of Cdk Activity
Leaky Scanning

